Major U.S. indexes were little changed at midday Thursday after Wednesday's big gains powered by strong bank earnings and a softer-than-expected inflation report.

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it had made less than analysts expected.

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on UnitedHealth (UNH – Research Report). The associated price target

Global shares are mostly higher following a rally on Wall Street driven by encouraging update on U.S. inflation. Oil prices slipped and U.S. futures edged higher.

The relatively modest moves for stocks came a day after they shot higher on hopes that an encouraging report on inflation may convince the Federal Reserve to deliver more cuts to interest rates this year. Treasury yields were also more placid in the bond market following mixed economic reports on Thursday..

The selloff in UnitedHealth's stock can be blamed for Dow futures falling, while S&P 500 and Nasdaq 100 futures are rising. The health giant's stock was sinking 3.2% in recent premarket trading, after

NEW YORK — U.S. stock indexes drifted lower Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies.

NEW YORK (AP) — U.S. stock indexes drifted lower Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies. The S&P 500 slipped 0.2% ...

First-quarter earnings season kicks off with results from Citigroup, Goldman Sachs, JPMorgan Chase, Wells Fargo, Bank of America, Morgan Stanley, and UnitedHealth Group.

NEW YORK — U.S. stock indexes drifted lower Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies. The Standard & Poor’s 500 ...

Analyst Erin Wright from Morgan Stanley maintained a Buy rating on UnitedHealth (UNH – Research Report) and keeping the price target at

The Global Equity composite fell 0.86% gross of fees in the fourth quarter, in line with the 0.89% decline of the MSCI ACWI Index.